more studies should be done.
I hope the delay with Ibogaine isn't as long as it was for MDMA.
So, probably easier to get a pass.
On the other hand, it doesn't look good from a toxicity standpoint, several people have died from it. It doesn't mean it can't work as treatment, after all, Tylenol can be deadly, but it may take some time to assess the risks. Also, it is notoriously hard to predict the effects of psychedelics, which can be a problem for designing a treatment.
It has however been quite some long time since I read on ibogaine, and if I recall correctly the effects lasted three days, which would indeed merit some check-in.